All Articles

Following a $25 million overhaul, the historic Sirata Beach Resort joins Hilton's Tapestry Collection, balancing heritage with a high-stakes growth strategy.

Viridian's Lumvoa gains FDA approval for Thyroid Eye Disease, challenging a blockbuster drug and validating DRI Healthcare's unique royalty investment model.

Hilton's inaugural ownership award to Canada's Gupta Group is more than a trophy; it's a strategic signal about the future of hospitality investment.

For the third year, Schneider Electric is TIME's most sustainable company. We look beyond the accolade at the strategy and real-world impact driving its success.

Comcast's plan to split its media and tech arms is more than a corporate shuffle; it's a stark admission that the age of the all-in-one conglomerate is over.

Philip Morris International partners with Andrea Bocelli for a 'smoke-free' future. Is it a genuine transformation or a masterful act of reputation laundering?

Rocket Lab's historic $8B Iridium deal creates a vertically integrated giant, set to reshape satellite communications, defense, and the entire space economy.

Korean Air partners exclusively with Freightos, giving forwarders real-time booking access. A major leap in air cargo's digital race for Asia's skies.

Beyond the hype, a Canadian digital bank is using AI to offer instant financing, targeting a multi-trillion-dollar U.S. market. Here's why it matters.

With its $752M Cardinal Midstream acquisition, Matador's San Mateo JV is building a system designed for dominance in the competitive Delaware Basin.

A $752M deal rocks the Delaware Basin as San Mateo acquires Cardinal Midstream. This isn't just consolidation; it's a strategic bet on the future of US gas.

The sale of a Chinese auto parts venture is more than a line item. It’s a signal of how global firms are rethinking strategy in a shifting landscape.

Gander Social launches with a bold promise: a Canadian-owned, privacy-first alternative. But can a network built on ideals survive in a world of giants?

In a major show of biotech investor confidence, Talawar Therapeutics is going public via a SPAC merger, securing $285M to advance its novel bispecific antibody.

IsoEnergy's evacuation in Saskatchewan is more than a safety drill. It's a preview of the operational and financial risks facing critical mineral supply chains.

X Square Robot's $2.8B valuation, backed by China's four tech giants, signals a strategic shift from digital screens to intelligent, physical robots.

As the nation turns 250, an alliance between the AKC and a health supplement brand uses ESPN to broadcast a new philosophy for pet care. Is it education or advertising?

A breakthrough oral vaccine from Singaporean scientists promises to end a devastating fish virus, bolstering food security and transforming aquaculture economics.

After a decade of quiet organic growth, Scalefusion is launching an aggressive channel-first strategy in ANZ with partner Unfold. Can it win the midmarket?